Furiex Pharmaceuticals, Inc.·4

Oct 14, 5:04 PM ET

BONDURANT STUART 4

4 · Furiex Pharmaceuticals, Inc. · Filed Oct 14, 2011

Insider Transaction Report

Form 4
Period: 2011-10-12
Transactions
  • Award

    Stock Options (to buy)

    2011-10-12+8,8258,825 total
    Exercise: $13.45Exp: 2021-10-12Common Stock (8,825 underlying)
Holdings
  • Common Stock

    3,896
  • Stock Options (to buy)

    Exercise: $13.94Exp: 2021-05-19Common Stock (8,675 underlying)
    8,675
  • Stock Options (to buy)

    Exercise: $9.11Exp: 2020-06-17Common Stock (17,570 underlying)
    17,570
Footnotes (3)
  • [F1]The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
  • [F2]The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
  • [F3]The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.

Documents

1 file
  • 4
    rrd323872.xmlPrimary

    FORM 4